Leading biotech and pharma spenders for three year M&As 2014
This statistic displays the leading ten biotechnology and pharmaceutical companies based on expenditure on mergers and acquisitions in three years, as of March 2014. During this time, Takeda spent 14.9 billion U.S. dollars on M&As with 7 deals.